One Stop Shop for All Your Market Research Reports

United States Paclitaxel Market by Manufacturers, States, Type and Application, Forecast to 2022

Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol". Scope of the Report: This report focuses on the Paclitaxel in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Manufacturers, this report covers Phyton ScinoPharm Novasep Samyang Polymed TAPI (Teva) Fresenius-kabi Southpharma Haiyao Huiang biopharma Yunnan Hande Hainan Yew Pharm Market Segment by States, covering California Texas New York Florida Illinois Market Segment by Type, covers Natural Paclitaxel Semi-synthetic Paclitaxel Market Segment by Applications, can be divided into Ovarian Cancer Cervical Cancer Breast Cancer Other There are 17 Chapters to deeply display the United States Paclitaxel market. Chapter 1, to describe Paclitaxel Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Paclitaxel, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Paclitaxel, for each state, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications; Chapter 12, Paclitaxel market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Paclitaxel Research Findings and Conclusion, Appendix, methodology and data source.
Table of Contents 1 Market Overview 1.1 Paclitaxel Introduction 1.2 Market Analysis by Type 1.2.1 Natural Paclitaxel 1.2.2 Semi-synthetic Paclitaxel 1.3 Market Analysis by Applications 1.3.1 Ovarian Cancer 1.3.2 Cervical Cancer 1.3.3 Breast Cancer 1.3.4 Other 1.4 Market Analysis by States 1.4.1 California Status an
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 4480
Corporate User US $8960
About this Report
Report ID 212643
Category
  • Healthcare
Published on 14-Aug
Number of Pages 123
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(9)